Deerfield Management Company »

N-able shares owned by Deerfield Management Company

Quarter-by-quarter ownership of N-able (NABL) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in N-able

Tip: Access up to 7 years of quarterly data

All positions including N-able held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in N-able by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $185k 14k 13.25

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding N-able

Silver Lake Group
Vanguard Group
Arrowpoint Asset Management
AlpInvest Partners B.V.
Dimensional Fund Advisors
Legal & General Group
Lexington Partners
Crescent Park Management
Norges Bank Investment Management
Lazard Asset Management
D. E. Shaw & Co
Bank of New York Mellon
Charles Schwab Investment Management
Lgt Capital Partners
Two Sigma Advisers

View all funds holding N-able